Safety and efficacy of isatuximab plus bortezomib, lenalidomide, and dexamethasone combined therapy for NDMM
Safety and efficacy of isatuximab plus bortezomib, lenalidomide, and dexamethasone combined therapy for NDMM
Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or carfilzomib in RRMM patients
Should every transplant eligible NDMM patient receive a transplant?
Vaccinations in myeloma patients including for COVID-19
Culture, Community and Communication in Advanced Disease in India
OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021
The role of the medical oncologist in the holistic care of patients with cancer in the Philippines
Predicting survival in NSCLC patients with poor performance status in resource-constrained settings
OncoAlert and ecancer weekly round up for July 19 - July 25, 2021
Part 3: How to test
The role of testing in prostate cancer treatment
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies